Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4875771
Max Phase: Preclinical
Molecular Formula: C16H9FO5
Molecular Weight: 300.24
Molecule Type: Unknown
Associated Items:
ID: ALA4875771
Max Phase: Preclinical
Molecular Formula: C16H9FO5
Molecular Weight: 300.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O
Standard InChI: InChI=1S/C16H9FO5/c17-12-4-2-1-3-9(12)10-5-8-6-11(15(19)20)16(21)22-14(8)7-13(10)18/h1-7,18H,(H,19,20)
Standard InChI Key: AURLBLPCECMPLX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 300.24 | Molecular Weight (Monoisotopic): 300.0434 | AlogP: 3.00 | #Rotatable Bonds: 2 |
Polar Surface Area: 87.74 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.09 | CX Basic pKa: | CX LogP: 2.86 | CX LogD: -1.01 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.71 | Np Likeness Score: -0.09 |
1. Wei L, Hou T, Li J, Zhang X, Zhou H, Wang Z, Cheng J, Xiang K, Wang J, Zhao Y, Liang X.. (2021) Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle., 64 (5.0): [PMID:33630609] [10.1021/acs.jmedchem.0c01624] |
Source(1):